CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 118 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,692 | -36.9% | 650 | -50.0% | 0.00% | – |
Q2 2023 | $15,359 | +86.4% | 1,300 | +100.0% | 0.00% | – |
Q1 2023 | $8,242 | +39147.6% | 650 | -60.6% | 0.00% | -100.0% |
Q4 2022 | $21 | -99.9% | 1,650 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $21,000 | 0.0% | 1,650 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $21,000 | -27.6% | 1,650 | -28.3% | 0.00% | – |
Q1 2022 | $29,000 | +1350.0% | 2,300 | +253.8% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 650 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | -33.3% | 650 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 650 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | -25.0% | 650 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | -20.0% | 650 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | – | 650 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $8,000 | -27.3% | 1,020 | 0.0% | 0.00% | – |
Q3 2018 | $11,000 | -15.4% | 1,020 | +2.0% | 0.00% | -100.0% |
Q2 2018 | $13,000 | -71.7% | 1,000 | -80.0% | 0.00% | -50.0% |
Q1 2018 | $46,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $46,000 | +15.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $40,000 | +73.9% | 5,000 | +25.0% | 0.00% | +100.0% |
Q2 2017 | $23,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |